Metabolism & Elimination Limited characterization of specific metabolic pathways has been published for both peptides: CJC-1295 (NO DAC): Peptidase-mediated degradation represents primary metabolic pathway Four amino acid substitutions provide enhanced resistance to dipeptidyl peptidase-IV Metabolites and degradation products not fully characterized in published literature Clearance from circulation within hours despite sustained pharmacodynamic effects Ipamorelin: Clearance of 0.078 L/h/kg in human pharmacokinetic studies Rapid elimination from plasma following distribution phase Metabolic pathways likely involve proteolytic cleavage at peptide bonds No significant accumulation observed with repeated dosing in animal models A notable pharmacokinetic-pharmacodynamic disconnect exists: despite relatively short plasma half-lives (30 minutes to 2 hours), growth hormone secretory effects persist for 6+ hours, suggesting either active metabolites, tissue retention, or persistent receptor signaling cascade activation
For related research compounds see our full range including MK677 Ibutamoren, RAD140 Testolone, Cardarine GW501516 and Ostarine MK2866
But then you hit the wall that stops most people cold
Separate investigations report BPC-157 effects on ligament healing, muscle injury models, and bone repair in rodents
A study published in PLOS ONE demonstrated that topical application of a tetravalent peptide resolved eczema in mouse models within 14 days, restoring normal epidermal morphology
